Early Transplant Arteriopathy in Kidney Transplantation.

[1]  M. Stegall,et al.  The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  S. Satchell,et al.  Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens. , 2019, Journal of the American Society of Nephrology : JASN.

[3]  T. Muthukumar,et al.  The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  P. Halloran,et al.  Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens. , 2015, Journal of the American Society of Nephrology : JASN.

[5]  E. Prossnitz,et al.  Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging. , 2014, Life sciences.

[6]  B. Kiberd,et al.  The impact of vascular anastomosis time on early kidney transplant outcomes , 2013, Transplantation research.

[7]  X. Jouven,et al.  Antibody-mediated vascular rejection of kidney allografts: a population-based study , 2013, The Lancet.

[8]  D. Brennan,et al.  Delayed Graft Function in the Kidney Transplant , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  M. Christiaans,et al.  Kidney Transplantation From Donors After Cardiac Death: A 25-Year Experience , 2010, Transplantation.

[10]  L C Racusen,et al.  Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  F. Cosio,et al.  Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  Giuseppe Remuzzi,et al.  Delayed graft function in kidney transplantation , 2004, The Lancet.

[13]  F. Kajiya,et al.  Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. , 2002, American journal of physiology. Renal physiology.

[14]  F. Luft,et al.  Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. , 2001, Kidney international.

[15]  H. E. Hansen,et al.  The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.

[16]  B. Burke,et al.  Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. , 1997, Journal of the American Society of Nephrology : JASN.

[17]  J. H. van Bockel,et al.  Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. , 1997, Transplantation.

[18]  A. Demetris,et al.  Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. , 1997, Clinical transplantation.

[19]  R. Wolfe,et al.  Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.

[20]  A. Gaber,et al.  The correlation of Banff scoring with reversibility of first and recurrent rejection episodes. , 1996, Transplantation.

[21]  P. Halloran,et al.  Delayed graft function in renal transplantation: etiology, management and long-term significance. , 1996, The Journal of urology.

[22]  M. Goligorsky,et al.  In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. , 1996, The Journal of clinical investigation.

[23]  W. Payne,et al.  THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG‐TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2 , 1994, Transplantation.

[24]  J. Robinette,et al.  Differences in vascular reactivity in models of ischemic acute renal failure. , 1991, Kidney international.

[25]  C. Valeri,et al.  Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. , 1989, The American journal of physiology.

[26]  V. Farewell,et al.  FACTORS INFLUENCING EARLY RENAL FUNCTION IN CADAVER KIDNEY TRANSPLANTS: A Case‐Control Study , 1988, Transplantation.

[27]  A. Leaf.  Cell Swelling: A Factor in Ischemic Tissue Injury , 1973, Circulation.

[28]  H. Ishida,et al.  Clinicopathologic analysis of acute vascular rejection cases after renal transplantation. , 2012, Transplantation proceedings.

[29]  G. Land,et al.  Single center experience of the effect of delayed function on outcome in retransplant recipients of cadaveric renal allografts. , 1991, Transplantation proceedings.

[30]  A. Leaf,et al.  The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. , 1972, The Journal of clinical investigation.